Atlas Trials

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis

Clinical trial NCT01440309 · UNKNOWN

Trial details

NCT number
NCT01440309
Sponsor
Robert Chunhua Zhao, MD, PhD
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Primary Biliary Cirrhosis
Start date
2011-11-01
Primary completion
2013-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.